Evidence map›Paper›PMID 11678610›Full record

ArticleMolecular and cellular biochemistry2001

In vivo reduction of chromium (VI) and its related free radical generation.

K J Liu, X Shi

Abstract read
PubMed
In one paragraph

Article in Molecular and cellular biochemistry, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 139 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Roles ofJournal of bacteriology · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The role of chelation in the treatment of other metal poisonings.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2013
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

K J LiuCollege of Pharmacy, University of New Mexico, Albuquerque 87131, USA.
X Shi
National Institute for Occupational Safety and Health · USUniversity of New Mexico · US

Funding

ENVIRONMENTAL RESPIRATORY DISEASE IN NATIVE AMERICANSP20ES009871 · NIEHS · UNIVERSITY OF NEW MEXICO · PI BURCHIEL, SCOTT W · 1999 to 2002
$1.2M
NIEHS NIH HHS PZO ES 09871
6 · The paper itself

Abstract

Chromium (VI) compounds are widely recognized as human carcinogens. Extensive studies in vitro and in model systems indicate that the reactive intermediate, Cr (V), generated by cellular reduction of Cr (VI), is likely the candidate for the ultimate carcinogenic form of chromium compounds. Here we review our current understanding of the in vivo reduction of Cr (VI) and its related free radical generation. Our results demonstrate that Cr (V) is indeed generated from the reduction of Cr (VI) in vivo, and that Cr (V) thus formed can mediate the generation of free radicals. Cr (V) and its related free radicals are very likely to be involved in the mechanism of Cr (VI)-induced toxicity and carcinogenesis. These studies also illustrate that in vivo EPR spectroscopy and magnetic resonance imaging can be very useful and powerful tools for studying paramagnetic metal ions in chemical and biochemical reactions occurring in intact animals.

Indexed as

AnimalsAntioxidantsChelating AgentsChromiumDrug InteractionsEdetic AcidElectron Spin Resonance SpectroscopyFree RadicalsKidneyLiverMagnetic Resonance ImagingMiceMice, Inbred BALB CModels, AnimalOxidation-ReductionReactive Oxygen SpeciesAntioxidantsChelating AgentsChromiumEdetic AcidFree RadicalsReactive Oxygen Species

Identifiers

PMID11678610
OpenAlexW1501653922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.